These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 889645)

  • 21. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
    Löscher W; Gerdes C; Richter A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):365-74. PubMed ID: 7845474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia-like reactions in three anesthetized horses.
    Manley SV; Kelly AB; Hodgson D
    J Am Vet Med Assoc; 1983 Jul; 183(1):85-9. PubMed ID: 6874529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
    Hackl W; Mauritz W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):534-7. PubMed ID: 2244439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 28. Noneffectiveness of verapamil in preventing halothane-induced malignant hyperthermia in susceptible swine.
    McGrath CJ; Lee JC; Rempel WE
    Am J Vet Res; 1984 May; 45(5):935-7. PubMed ID: 6732027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and metabolic manifestations of acute endotoxin infusion in pigs with and without the malignant hyperthermia mutation.
    Musley SK; Beebe DS; Komanduri V; Iaizzo PA; Belani KG
    Anesthesiology; 1999 Sep; 91(3):833-8. PubMed ID: 10485795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo induced malignant hyperthermia in pigs. III. Localization of calcium in skeletal muscle mitochondria by means of electronmicroscopy and microprobe analysis.
    Stadhouders AM; Viering WA; Verburg MP; Ruitenbeek W; Sengers RC
    Acta Anaesthesiol Scand; 1984 Feb; 28(1):14-26. PubMed ID: 6711259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Capnography and anesthetic-induced malignant hyperthermia].
    Krivosic-Horber R; Theunynck D; Adnet P
    Agressologie; 1985 Nov; 26(11):929-32. PubMed ID: 3938623
    [No Abstract]   [Full Text] [Related]  

  • 32. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia.
    Relton JE
    Int Anesthesiol Clin; 1979; 17(4):141-51. PubMed ID: 521179
    [No Abstract]   [Full Text] [Related]  

  • 34. [Malignant hyperthermia in swine during isoflurane anesthesia].
    Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
    Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
    Allen PD; López JR; Sánchez V; Ryan JF; Sreter FA
    Anesthesiology; 1992 Jan; 76(1):132-8. PubMed ID: 1729917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior hypothermia attenuates malignant hyperthermia in susceptible swine.
    Iaizzo PA; Kehler CH; Carr RJ; Sessler DI; Belani KG
    Anesth Analg; 1996 Apr; 82(4):803-9. PubMed ID: 8615501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
    Katz DN
    CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.